The Food and Drug Administration granted 501(k) clearance to a muscle and joint rehabilitation medical device developed by OHSU Scientist Dr. Paul Cordo, Ph.D., and AMES Technology, Inc. To read the full news release click HERE. May 22, 2013 Medical device manufacturer Neuro Kinetics Inc. has licensed software from OHSU that helps researchers better understand abnormalities within vestibular systems. Read the full post HERE.
May 15, 2013
Breast and prostate cancer tests are just the beginning of the Cepheid collaboration with OHSU. Read the full article HERE.
May 10, 2013
Read about the fifth annual Willamette Angel Conference results in the Portland Business Journal. This year's investors doubled the amount of investment from the previous record. To read the full article click HERE.
March 12, 2013
Have questions about when to contact TTBD or what we can offer? Join us for a brown bag presentation and Q&A on "TTBD: An Overview" on Wednesday, April 3, 2013 from 12:00-1:00pm in the Marquam Room. Click here for more details.
2012 Technology Innovation Awardees Each year the office of Technology Transfer & Business Development honors OHSU students, faculty, and staff for their dedication to innovation and entrepreneurship at OHSU. During fiscal year 2012, the TTBD office completed 81 industry sponsored research agreements, totaling over $12.8 million in awards. Other key measures of OHSU's progress in moving discoveries toward commercialization included 117 invention disclosures, involving 209 OHSU inventors, with over 50% being first time OHSU inventors. For a full list of Technology Innovation Award recipients, view the 2012 Technology Innovation Awards program.
November 1, 2011
Patent Issed for OHSU Stem Cell Cloning Oregon Health & Science University's unique method of transforming a person's own skin cells into stem cells has officially been patented. The United States Patent and Trademark Office, an agency within the U.S. Department of Commerce, issued the patent earlier this year. Read More.
Aug 29, 2011
Gentel Biosciences Announces Agreement with Oregon Health & Science University Gentel Biosciences, a provider of animal health research products, announces today an agreement with Oregon Health & Science University (OHSU) to license viral antigens for use in Gentel's Colony Surveillance Assays (CSA). The antigens were developed at the molecular virology core at OHSU's Oregon National Primate Research Center.
Oregon Innovation Showcase 2010 Thank you to all attendees - Online Program AvailableThe 2010 Innovation Showcase: The Design and Development of Medical Devices featured presentations from Oregon's four premier research universities and local medical device companies.Over 200 individuals from local bioscience companies, academic institutions, and the business community enjoyed an afternoon of science and networking. Thank you to all who attended.
November 4, 2010
5.4 Million Headed to Oregon Biomedical Startups Biomedical companies in Oregon secured $5.4 million from the new Therapeutic Discovery Project Program, including four OHSU Startup Companies. Lawmakers designed the program to provide tax credits and grants to small firms "that show significant potential to produce new therapies, address unmet medical needs, reduce the long-term growth of health care costs, or advance the goal of curing cancer within the next 30 years," according to the Department of Health and Human Services, which runs the program. Read More.
October 13, 2010
OHSU Innovation and Technology Transfer Activities Up in a Down Year Despite the challenging economic climate, the OHSU technology transfer metrics demonstrate continued progress. This October, during its annual Technology Innovation Awards ceremony, Oregon Health & Science University will honor more than 100 OHSU researchers who have had a discovery licensed, a patent issued, or an invention that led to the creation of a startup company during fiscal year 2010. Read More